Search

Type 2 diabetes, Body weight, Telemedicine, Lockdown, HbA1c Keywords: Type 2 diabetes; Lockdown; HbA1c; Body weight; Telemedicine EN Type 2 diabetes Lockdown HbA1c Body weight Telemedicine 281 284 4 02/15/22 20220201 NES 220201 Introduction The lockdown measures for COVID-19 could interfere with the management of diabetes. [Extracted from the article]

The article reports that despite the effectiveness of mRNA vaccines in preventing severe coronavirus disease 2019, infections occur in vaccinated individuals especially in the case of hyperglycemia. Topics include examines although COVID-19–related inflammation, even in its mild forms, could increase glycemia, glucose control during breakthrough infection in type 1 diabetes has not been studied so far.

The study examined the glycaemic response to pasta made from three different wheat varieties in individuals with type 2 diabetes. The research found that there were no significant advantages in post-prandial glucose control when using ancient wheat varieties like Khorasan or Senatore Cappelli compared to the modern wheat variety Claudio. The macronutrient composition of the pasta was similar across all three varieties, and the differences in post-prandial glucose response were clinically trivial. The study suggests that individuals with type 2 diabetes can choose pasta based on personal taste preferences without worrying about minor differences in glucose levels. [Extracted from the article]

On the other hand, since diabetes is associated with a worse outcome of COVID-19 [[3]], vaccination is particularly recommended in patients with T1D. Keywords: COVID-19; Diabetes; Vaccine EN COVID-19 Diabetes Vaccine 435 438 4 02/23/22 20220301 NES 220301 Introduction In the available phase 3 trial, mRNA-1273 (Moderna) COVID-19 vaccine showed a high efficacy together with a good tolerability [[1]]. Since vaccination does not imply any relevant negative consequence on glycemic control, concerns about the effects of vaccine on glycemia should not contribute to vaccine hesitancy in people with T1D diabetes, and this is especially important for advocating clearly about the need for vaccinate all these subjects against COVID-19. [Extracted from the article]